RSNA: Visage previews universality, mobility

| | Health Imaging | Artificial Intelligence

Visage Imaging (Booth # 6249) is demonstrating works-in-progress capabilities built into its enterprise viewing technology at RSNA 2012, Nov. 25-30, in Chicago.

Visage is showcasing the extension of its cardiac capabilities, which include cardiac CT angiography, left ventricle analysis and calcium scoring. Cardiac works-in-progress includes enhanced cardiac display protocols for angiography and echocardiography studies, display of multiple concurrent cine views, as well as ECG synchronized display of pre- and post-stress echocardiography.

The company is demonstrating support for iPhone 5 and other enhancements to its Visage Ease 1.2.3 for mobile imaging results. Visage is showing push notifications for Visage Ease as a work-in-progress, as well as support for the attachment of photographs and screen captures from iOS devices.

Visage Imaging is offering synchronized QA for enterprise imaging users who have Acuo Technologies’ Universal Clinical Platform (UCP), a vendor-neutral archive. This toolset provides HL7 standards-based integration to Acuo’s UCP to integrate typical quality assurance functionality like edit, merge and delete.

Related Content

Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.